Article Versions Notes

Tang C, Chua YC, Abdin E, Subramaniam M, Verma S. Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study. International Journal of Environmental Research and Public Health. 2022; 19(1):137. https://doi.org/10.3390/ijerph19010137

Tang, Charmaine, Yi Chian Chua, Edimansyah Abdin, Mythily Subramaniam, and Swapna Verma. 2022. "Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study" International Journal of Environmental Research and Public Health 19, no. 1: 137. https://doi.org/10.3390/ijerph19010137

Tang, C., Chua, Y. C., Abdin, E., Subramaniam, M., & Verma, S. (2022). Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study. International Journal of Environmental Research and Public Health, 19(1), 137. https://doi.org/10.3390/ijerph19010137